• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dynamic Pharmaceuticals Invesco ETF (NY: PJP )

    89.61 +0.74 (+0.84%)
    Official Closing Price Updated: 8:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Dynamic Pharmaceuticals Invesco ETF

    FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
    The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak. 
    Via Benzinga
    Topics ETFs
    Exposures COVID-19 Product Safety
    COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
    Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected by Sept. 
    Via Benzinga
    Exposures COVID-19
    Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
    The Supreme Court has rejected Purdue Pharma's bankruptcy plan, exposing the Sackler family to lawsuits over their role in the opioid crisis. This decision impacts victims, state and local governments,... 
    Via Benzinga
    Topics Bankruptcy Lawsuit
    Exposures Financial Legal
    A Look At Pharma ETFs Post Q1 Earnings
    Pharma ETFs have delivered mixed performances over the past month. 
    Via Talk Markets
    Topics ETFs
    A Look At Pharma ETFs After Q4 Earnings
    The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. 
    Via Talk Markets
    Topics ETFs
    Government-granted Patent Monopolies Are Not The Free Market
    Our system for developing new drugs is a disaster. While we can point to great successes, they come at enormous cost. We will spend over $600B this year on prescription and non-prescription drugs -... 
    Via Talk Markets
    Topics Intellectual Property
    Exposures Intellectual Property
    Time For Gilead Sciences-Heavy ETFs?
    Gilead Sciences has underperformed the broader market this year by a hefty margin. 
    Via Talk Markets
    Pharma ETFs in Focus Post Q2 Earnings
    Second-quarter earnings for the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 30.7% on 5% revenue growth. 
    Via Talk Markets
    Topics ETFs
    Want to Invest in Pharmaceutical Stocks but Don't Know How? Try This ETF.
    Simplify your exposure to an ever-changing prescription drug market with this rules-based fund. 
    Via The Motley Fool
    Pharma ETFs Gain Post Q1 Earnings
    Pharma ETFs have been in the green over the past month. 
    Via Talk Markets
    A Look At Pharma ETFs Post Q4 Earnings
    Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month. 
    Via Talk Markets
    Pharma ETFs In Focus Post Q3 Earnings
    Many industry bigwigs reported solid results with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month. 
    Via Talk Markets
    Wave of Solid Q3 Earnings Push Pharma ETFs Higher
    The slew of Q3 results has led to smooth trading in pharma ETFs over the past month. 
    Via Talk Markets
    Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
    Investors have one more reason to cheer the COVID-19 vaccine update as the FDA has approved emergency use of a booster dose of the Pfizer Inc. and BioNTech SE COVID-19 vaccine. 
    Via Talk Markets
    Exposures COVID-19 Product Safety
    3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
    The pharmaceutical industry has benefited from much investor attention amid the COVID-19 pandemic. 
    Via Talk Markets
    Exposures COVID-19
    3 Cheap Pharmaceutical Stocks to Grab Now
    The pharmaceutical industry has been the beneficiary of significant investor attention amid the COVID-19 pandemic as society turned to its products to fight the coronavirus. 
    Via Talk Markets
    Exposures COVID-19
    Pharma ETFs in Focus Post Q1 Earnings
    The slew of Q1 results has led to mixed trading in pharma ETFs over the past month. Here are those in detail. 
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.